177 related articles for article (PubMed ID: 23377817)
21. GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis.
Beringer PM; Hidayat L; Heed A; Zheng L; Owens H; Benitez D; Rao AP
J Cyst Fibros; 2009 Jan; 8(1):19-25. PubMed ID: 18799365
[TBL] [Abstract][Full Text] [Related]
22. Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period.
Şahin A; Erten Ş; Altunoğlu A; Işıkoğlu S; Neşelioğlu S; Ergin M; Atalay HV; Erel Ö
Acta Reumatol Port; 2014; 39(4):316-21. PubMed ID: 25007287
[TBL] [Abstract][Full Text] [Related]
23. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.
Aybal Kutlugün A; Yildirim T; Altindal M; Arici M; Yasavul U; Turgan C
Ren Fail; 2010; 32(10):1230-2. PubMed ID: 20954987
[TBL] [Abstract][Full Text] [Related]
24. Esophageal motor function in Familial Mediterranean Fever: a prospective evaluation of motility in 31 patients.
Bektaş M; Doğanay B; Alkan M; Ustun Y; Soykan I
Eur J Intern Med; 2009 Sep; 20(5):548-50. PubMed ID: 19712864
[TBL] [Abstract][Full Text] [Related]
25. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
26. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?
Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G
Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539
[TBL] [Abstract][Full Text] [Related]
27. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever.
Yildiz A; Akkaya V; Kiliçaslan I; Türkmen A; Görçin B; Atilgan D; Sever MS
J Nephrol; 2001; 14(2):125-7. PubMed ID: 11411014
[TBL] [Abstract][Full Text] [Related]
28. Serum soluble fas ligand levels in familial Mediterranean fever.
Ceri M; Unverdi S; Senes M; Altay M; Yilmaz R; Yucel D; Duranay M
Ren Fail; 2013 Jul; 35(6):835-7. PubMed ID: 23682624
[TBL] [Abstract][Full Text] [Related]
29. Morphological aspects of the familial Mediterranean fever.
Ambartsymian SV
Georgian Med News; 2012 Mar; (204):59-62. PubMed ID: 22573750
[TBL] [Abstract][Full Text] [Related]
30. Interaction between periodontal disease and systemic secondary amyloidosis: from inflammation to amyloidosis.
Cengiz Mİ; Yayla N; Cengiz K; Bagci H; Taşkın E
J Periodontol; 2011 Apr; 82(4):566-74. PubMed ID: 21043797
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
Keven K; Sengul S; Kutlay S; Ekmekci Y; Anadol E; Nergizoglu G; Ates K; Erturk S; Erbay B
Transplant Proc; 2004 Nov; 36(9):2632-4. PubMed ID: 15621109
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal mucosal involvement without amyloidosis in children with familial Mediterranean fever.
Gurkan OE; Dalgic B
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):319-23. PubMed ID: 23591909
[TBL] [Abstract][Full Text] [Related]
33. QT variability in amyloidosis of familial Mediterranean fever.
Nussinovitch U; Ben-Zvi I; Livneh A
Isr Med Assoc J; 2012 Apr; 14(4):225-8. PubMed ID: 22675838
[TBL] [Abstract][Full Text] [Related]
34. Is colchicine therapy effective in all patients with secondary amyloidosis?
Unverdi S; Inal S; Ceri M; Unverdi H; Batgi H; Tuna R; Ozturk MA; Guz G; Duranay M
Ren Fail; 2013 Sep; 35(8):1071-4. PubMed ID: 23841746
[TBL] [Abstract][Full Text] [Related]
35. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever.
Altindal M; Turkmen E; Yildirim T; Yilmaz R; Aki FT; Arici M; Altun B; Erdem Y
Clin Transplant; 2016 Jul; 30(7):787-90. PubMed ID: 27101228
[TBL] [Abstract][Full Text] [Related]
36. Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever.
Karatay S; Yildirim K; Uyanik A; Uzkeser H; Kiziltunc A; Ugur M; Baygutalp F; Acemoglu H
Ann Clin Lab Sci; 2010; 40(1):10-4. PubMed ID: 20124324
[TBL] [Abstract][Full Text] [Related]
37. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
Livneh A
Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
[TBL] [Abstract][Full Text] [Related]
38. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever.
Akcan Y; Bayraktar Y; Arslan S; Van Thiel DH; Zerrin BC; Yildiz O
Eur J Med Res; 2003 Jul; 8(7):304-6. PubMed ID: 12911867
[TBL] [Abstract][Full Text] [Related]
39. Diffuse pulmonary amyloidosis that mimics interstitial lung disease in a patient with familial Mediterranean fever.
Erdem H; Simşek I; Pay S; Dinc A; Deniz O; Ozcan A
J Clin Rheumatol; 2006 Feb; 12(1):34-6. PubMed ID: 16484879
[TBL] [Abstract][Full Text] [Related]
40. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
